1. FDA notification (2008) FDA Public Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of Pelvic Organ Prolapse and Stress Urinary Incontinence. http://wayback.archive-it.org/7993/20170111190506/http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm061976.htm Accessed 13/1/2020.
2. FDA (2011) Considerations about Surgical Mesh for SUI. https://wayback.archive-it.org/7993/20170404140406/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ObstetricsandGynecologyDevices/UCM270402.pdf Accessed 13/1/2020.
3. MHRA (2012) Summaries of safety/adverse effects of vaginal tapes/slings/meshes for stress urinary incontinence and prolapse.
4. Ford A, Rogerson L, Cody J, Aluko P, Ogah J. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Incontinence Group. 2017. https://doi.org/10.1002/14651858.CD006375.pub4.
5. Keltie K, Elneil S, Monga A, Patrick H, Powell J, Campbell B, Sims A (2017) Complications following vaginal mesh procedures for stress urinary incontinence: an 8 year study of 92,246 women. Scientific reports 7, article number: 12015.